BIOMAT Database Logo BIOMAT Database Logo

[Variations in fecal elimination of uric acid in 8 patients treated with benzbromarone]. 1983

Y Dupuich, and C Chandelier, and G Niquet

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001553 Benzbromarone Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout. Acifugan,Benzbromaron,Benzbromaron AL,Benzbromaron-Ratiopharm,Besuric,Desuric,Narcaricin,Urinorm,AL, Benzbromaron,Benzbromaron Ratiopharm
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid

Related Publications

Y Dupuich, and C Chandelier, and G Niquet
[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
September 1976, Fortschritte der Medizin,
Y Dupuich, and C Chandelier, and G Niquet
[Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
November 1970, Deutsche medizinische Wochenschrift (1946),
Y Dupuich, and C Chandelier, and G Niquet
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
October 1995, European journal of medical research,
Y Dupuich, and C Chandelier, and G Niquet
[Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
May 1979, Fortschritte der Medizin,
Y Dupuich, and C Chandelier, and G Niquet
[Renal elimination of uric acid in gout patients with crystalluria or uric calculi].
July 1955, Archivos espanoles de urologia,
Y Dupuich, and C Chandelier, and G Niquet
[On the decrease of uric acid level in the plasma with benzbromarone].
December 1968, Klinische Wochenschrift,
Y Dupuich, and C Chandelier, and G Niquet
Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
June 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Y Dupuich, and C Chandelier, and G Niquet
[Long-term therapy with benzbromarone in uric arthritis].
September 1975, Wiener medizinische Wochenschrift (1946),
Y Dupuich, and C Chandelier, and G Niquet
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
January 1991, Advances in experimental medicine and biology,
Y Dupuich, and C Chandelier, and G Niquet
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
February 1990, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!